why choose us

First received: April 28, 2023

Clinical Trial: A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Macular Edema Secondary to Retinal Vein Occlusion

Study Type: INTERVENTIONAL


Official Title: Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion

Brief Summary: Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood vessel that carries blood away from the retina (vein) becomes blocked.The retina is the very back part of the eye.The blocked vein causes fluid and blood to leak into the retina and thereby causes a swelling of the macula (the center of the retina responsible for fine vision).This swelling is called macular edema.When a vein in the retina is blocked, the levels of a…

Read more